RxDoctor Payments Data

Douglas Woida, PA

Physician Assistant · Milwaukee, WINPI 1790823045

Payments from drug & device makers

$4,808in general payments, 2019–2025

Across 270 payments — averaging $17.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$1K
  • AbbVie$1K
  • Lilly USA, LLC$569
  • Boehringer Ingelheim$369
  • Phathom Pharmaceuticals, Inc.$307
  • Otsuka America Pharmaceutical, Inc.$254
  • plus $1K from 18 others

What the payments were for

  • Food & beverage$4,69298%
  • Education$1162%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,808 in reported general payments places this provider in the 95th percentile of 2,804 physician assistant providers in Wisconsin.

See all physician assistant providers in Wisconsin

Medicare billing

Part B allowed, 2024
$12,358
Medicare patients
40
Services billed
162

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin60$70,009
FarxigaDapagliflozin Propanediol40$50,690
LinzessLinaclotide44$35,411
JanuviaSitagliptin Phosphate29$32,467
UbrelvyUbrogepant11$18,191
TradjentaLinagliptin21$17,405
EliquisApixaban12$8,513
Breztri AerosphereBudesonide/Glycopyr/Formoterol12$7,136
Fluticasone-SalmeterolFluticasone Propion/Salmeterol16$4,645
Lidocaine31$2,350
Albuterol Sulfate HfaAlbuterol Sulfate78$2,202
Lantus SolostarInsulin Glargine,hum.Rec.Anlog15$2,130
Omega-3 Acid Ethyl Esters29$1,784
Famotidine59$1,289
Atorvastatin Calcium156$1,155

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance, Tradjenta$369$87,41481 claims
AstraZenecaFarxiga, Breztri Aerosphere$1,161$57,82652 claims
AbbVieLinzess, Ubrelvy$1,012$53,60255 claims
MerckJanuvia$16$32,46729 claims
PfizerEliquis$18$8,51312 claims
Amneal Pharmaceuticals LLCLevothyroxine Sodium$45$42144 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,804 physician assistant providers in Wisconsin.

Other physician assistant in Milwaukee

See the full list for Wisconsin

Where these figures come from

Is this you, or does something look wrong? →